Michelle Chen, Ph.D. Receives Top 25 Biotech Executive Award (IMAGE)
Caption
At Insilico, Dr. Chen is responsible for guiding the Company’s strategies, corporate development, and global business development, and she has led numerous strategic partnering agreements on Insilico’s novel AI-designed drugs with leading pharmaceutical companies
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content